首页> 外国专利> USE OF THE COMPOUND 2-3-(2-CHLOROETHYL)-3-NITROSOUREIDO-1,3-PROPANEDIOL ORALLY FOR THE TREATMENT OF MELANOMA B16, EHRLICH TUMOR, SARCOMA 180, SARCOMA 37, LYMPHOSARCOMA LIO-1 AND CARCINOSARCOMA WALKER 256 EXPERIMENTALLY IN MICE AND RATS

USE OF THE COMPOUND 2-3-(2-CHLOROETHYL)-3-NITROSOUREIDO-1,3-PROPANEDIOL ORALLY FOR THE TREATMENT OF MELANOMA B16, EHRLICH TUMOR, SARCOMA 180, SARCOMA 37, LYMPHOSARCOMA LIO-1 AND CARCINOSARCOMA WALKER 256 EXPERIMENTALLY IN MICE AND RATS

机译:化合物2- [3-(2-氯乙基)-3-硝基磺脲基] -1,3-丙二醛的配伍用于治疗黑色素B16,EHRLICH肿瘤,SARCOMA 180,SARCOMA 37,淋巴肉瘤LIO-1和癌肉瘤行者256小鼠和大鼠的实验

摘要

FIELD: medicine.;SUBSTANCE: invention refers to medicine, and concerns using compound of 2-[3-(2-chloroethyl)-3-nitrosoureido]-1,3-propanediol orally for treating melanoma B16, Ehrlich tumors, sarcoma 180, sarcoma 37, lymphosarcoma LIO-1 and carcinosarcoma Walker 256 experimentally in mice and rats.;EFFECT: invention extends range of agents for treating malignant tumors.;1 cl, 9 ex, 14 dwg, 22 tbl
机译:领域:药物:本发明涉及药物,并且涉及使用2- [3-(2-氯乙基)-3-亚硝基脲基] -1,3-丙二醇的化合物口服治疗黑色素瘤B16,埃氏肿瘤,肉瘤180,在小鼠和大鼠中实验性地观察到肉瘤37,淋巴肉瘤LIO-1和癌肉瘤Walker256。效果:本发明扩展了治疗恶性肿瘤的药物范围; 1 cl,9 ex,14 dwg,22 tbl

相似文献

  • 专利
  • 外文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号